GLP-3 Reta “Triple G” refers to retatrutide, also known by the research identifier LY3437943. Retatrutide is an investigational peptide characterized as a triple receptor agonist with activity at the GIP, GLP-1, and glucagon receptors.
The “Triple G” designation refers to these three receptor targets. Although the term “GLP-3” is sometimes used informally to describe the compound, retatrutide is more accurately classified as a GIP, GLP-1, and glucagon triple receptor agonist.
This product is offered in 5-pack and 10-pack formats for controlled laboratory, biochemical, receptor-focused, and analytical research.
Product Details
- Compound: Retatrutide
- Research identifier: LY3437943
- Common research name: Reta / Triple G
- Classification: Investigational peptide
- Research targets: GIP, GLP-1, and glucagon receptors
- Available formats: 5-pack and 10-pack
- Form: Research peptide vials
- Intended use: Laboratory and analytical research
